Reinventing the Sequencer

Helicos' Bill Efcavitch is confident that he can produce a machine that can sequence a genome for $1,000 in ten days. It hasn't been an easy road.

kerry grens
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

While giving a tour of Helicos BioSciences' laboratories in Cambridge, Mass., Bill Efcavitch pauses and pats a refrigerator-size 3700 DNA sequencer. The sequencer was made by Applied Biosystems, where Efcavitch worked until 2004. "It's the platform that sequenced the human genome," says Efcavitch, Helicos' senior vice president of product research and development, "and I managed the group that did that." Now, the instrument he helped develop (which Helicos purchased in the used market) serves as an analytical tool to back up a new style of genome sequencer that Efcavitch is developing. Helicos promises to deliver what the many model 3700 instruments did for millions of dollars in several years for just $1,000 in 10 days.

Like Efcavitch's projects before it, Helicos' HeliScope sequencer is an exercise in ambition. A prototype, also a refrigerator-size box, stands in Helicos' engineering department. Efcavitch pulls open a door on the box, revealing a touch-screen ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • kerry grens

    Kerry Grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo